Clinical Trial Update: Phase I, Open Label, Single Center Safety Study of [F-18]FLT [Phase 1]

View source ↗

Summary

Phase I, open-label safety study of 18F-FLT (fluorothymidine) for brain cancer conducted at a single center; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• 18F-FLT (fluorothymidine)

Snippet

Sponsor: Siemens Molecular Imaging | Conditions: Brain Cancer | Phase 1 | Status: COMPLETED